ARMP vs BIIB: Which Stock is Better?
Side-by-side comparison of Armata Pharmaceuticals Inc and Biogen Inc in 2026
ARMP
Armata Pharmaceuticals Inc
$10.60
BIIB
Biogen Inc
$184.87
Key Metrics Comparison
| Metric | ARMP | BIIB | Winner |
|---|---|---|---|
| Market Cap | $385.91M | $27.13B | BIIB |
| P/E Ratio | N/A | 21.42 | BIIB |
| EPS (TTM) | $N/A | $8.63 | BIIB |
| Revenue Growth | -0.6% | -0.1% | BIIB |
| Gross Margin | -416.4% | 78.9% | BIIB |
Analyze ARMP
Full quant analysis
Analyze BIIB
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ARMP or BIIB a better investment?
Comparing ARMP and BIIB: Armata Pharmaceuticals Inc has a market cap of $385.91M while Biogen Inc has $27.13B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ARMP and BIIB?
ARMP (Armata Pharmaceuticals Inc) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ARMP or BIIB?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ARMP or BIIB?
BIIB has higher revenue growth at -0.1% vs -0.6% for ARMP.
Which company is more profitable: ARMP or BIIB?
Biogen Inc (BIIB) has higher gross margins at 78.9% compared to -416.4% for ARMP.
Which is the larger company: ARMP or BIIB?
Biogen Inc (BIIB) is larger with a market cap of $27.13B compared to $385.91M for ARMP.
Should I buy ARMP or BIIB in 2026?
Both ARMP and BIIB have investment merit. ARMP trades at $10.60 while BIIB trades at $184.87. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ARMP and BIIB stock?
Key differences: Market Cap ($385.91M vs $27.13B), P/E Ratio (N/A vs 21.4x), Revenue Growth (-0.6% vs -0.1%), Gross Margin (-416.4% vs 78.9%).